Acelyrin, Inc.
SLRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $312 | $524 | $368 | $368 |
| - Cash | $74 | $218 | $279 | $102 |
| + Debt | $6 | $1 | $0 | $0 |
| Enterprise Value | $244 | $307 | $89 | $266 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$248 | -$382 | -$65 | -$42 |
| % Margin | – | – | – | – |
| Net Income | -$248 | -$382 | -$250 | -$42 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.5 | -5.43 | -0.7 | -2.05 |
| % Growth | 54% | -675.7% | 65.9% | – |
| Operating Cash Flow | -$304 | -$170 | -$62 | -$5 |
| Capital Expenditures | -$1 | -$12 | $0 | -$25 |
| Free Cash Flow | -$305 | -$182 | -$62 | -$30 |